FDA Device Intelligence
HomeMERIDIAN BIOSCIENCE, INC. › illumigene Group B Streptococcus

illumigene Group B Streptococcus

MERIDIAN BIOSCIENCE, INC. · Model 280350 · UDI-DI 00840733101342

NJR Prescription
10
510(k) clearances
79
Adverse events
11
Recalls
13
Facilities

Description

The illumigene Group B Streptococcus (GBS) assay, performed on the illumipro-10, is a qualitative in vitro diagnostic for the detection of Streptococcus agalactiae in enriched cultures obtained from vaginal/rectal swab specimens from antepartum women. Enriched cultures are obtained by 18-24 hour incubation of vaginal/rectal swab specimens in selective broth medium, either Lim Broth, TransVag Broth or Carrot Broth. The illumigene GBS assay utilizes loop-mediated isothermal DNA amplification (LAMP) technology to detect Streptococcus agalactiae by targeting a segment of the Streptococcus agalactiae genome. Results from the illumigene GBS assay can be used as an aid in establishing the GBS colonization status of antepartum women. This assay does not diagnose or monitor treatment for GBS infections.

Recalls

DateFirmReason
2025-10-07Meridian Bioscience IncThe cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.
2024-12-19Becton Dickinson & Co.Potential for signal drift in specific lots of BD PCR Cartridges.
2024-12-13Hologic, Inc.Potential weak pouch seal on Panther Fusion GBS assay cartridge, causing potential for invalid or incorrect results leading to a possible delay of treatment.
2022-03-18Hologic, IncSamples, run on a GBS Assay, that have analyte concentrations that are at or near the limit of detection may produce false negative results.
2019-02-20Luminex CorporationThrough internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially
2015-11-23Biomerieux IncFDA has determined that the product requires 510(k) clearance to continue marketing/distribution in the United States.
2013-05-31Becton Dickinson & Co.Electrical power module installed on some in vitro diagnostic instruments does not meet industry standards as labeled.
2012-12-11Becton Dickinson & Co.Cartridges are not sealing properly during PCR testing and may cause false results, indeterminates and/or invalid runs.
2012-09-18Becton Dickinson & Co.Clinical diagnostic instrument may exhibit minor defects, which could lead to erroneous test results.
2011-04-01CepheidA mismatch of Patient ID or Sample ID and the Host Order from the hosted LIS and its requested test results could occur when running in batch mode and cartridges are introduced in

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.